#cetuximab

8 Books
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial - Jensen,, Krauss, Jürgen, Potthoff, Karin, Simon, Christian, Nikoghosyan,, Lossner, Karen, Debus, Jürgen, Münter,
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
Jensen,, Krauss, Jürgen, Potthoff, Karin, Simon, Christian, Nikoghosyan,, Lossner, Karen, Debus, Jürgen, Münter,
9 Pages
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study - Ulivi, Paola, Capelli, Laura, Valgiusti, Martina, Zoli, Wainer, Scarpi, Emanuela, Chiadini, Elisa, Rosetti, Paola, Bravaccini, Sara, Calistri, Daniele, Saragoni, Luca, Gardini, Andrea, Ragazzini, Angela, Frassineti, Giovanni, Amadori, Dino, Passardi, Alessandro
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
Ulivi, Paola, Capelli, Laura, Valgiusti, Martina, Zoli, Wainer, Scarpi, Emanuela, Chiadini, Elisa, Rosetti, Paola, Bravaccini, Sara, Calistri, Daniele, Saragoni, Luca, Gardini, Andrea, Ragazzini, Angela, Frassineti, Giovanni, Amadori, Dino, Passardi, Alessandro
8 Pages
Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab - Meira,, Almeida,, Mororó,, Caetano,, Nóbrega,, Batista, Delano, Sternberg, Cinthya, Ferreira,
Efficient Blockade of Akt signaling is a determinant factor to overcome resistance to Matuzumab
Meira,, Almeida,, Mororó,, Caetano,, Nóbrega,, Batista, Delano, Sternberg, Cinthya, Ferreira,
13 Pages
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines - Cavazzoni, Andrea, Alfieri,, Cretella, Daniele, Saccani, Francesca, Ampollini, Luca, Galetti, Maricla, Quaini, Federico, Graiani, Gallia, Madeddu, Denise, Mozzoni, Paola, Galvani, Elena, La, Bonelli, Mara, Fumarola, Claudia, Mutti, Antonio, Carbognani, Paolo, Tiseo, Marcello, Barocelli, Elisabetta, Petronini,, Ardizzoni, Andrea
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Cavazzoni, Andrea, Alfieri,, Cretella, Daniele, Saccani, Francesca, Ampollini, Luca, Galetti, Maricla, Quaini, Federico, Graiani, Gallia, Madeddu, Denise, Mozzoni, Paola, Galvani, Elena, La, Bonelli, Mara, Fumarola, Claudia, Mutti, Antonio, Carbognani, Paolo, Tiseo, Marcello, Barocelli, Elisabetta, Petronini,, Ardizzoni, Andrea
14 Pages
EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis - Yang, Zu-Yao, Shen, Wei-Xi, Hu, Xue-Feng, Zheng, Da-Yong, Wu, Xin-Yin, Huang, Ya-Fang, Chen, Jin-Zhang, Mao, Chen, Tang,, Tang, Jin-Ling
EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
Yang, Zu-Yao, Shen, Wei-Xi, Hu, Xue-Feng, Zheng, Da-Yong, Wu, Xin-Yin, Huang, Ya-Fang, Chen, Jin-Zhang, Mao, Chen, Tang,, Tang, Jin-Ling
9 Pages
Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients - Gerber, Peter, Meller, Stephan, Eames, Tatiana, Buhren, Bettina, Schrumpf, Holger, Hetzer, Sonja, Ehmann, Laura, Budach, Wilfried, Bölke, Edwin, Matuschek, Christiane, Wollenberg, Andreas, Homey, Bernhard
Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients
Gerber, Peter, Meller, Stephan, Eames, Tatiana, Buhren, Bettina, Schrumpf, Holger, Hetzer, Sonja, Ehmann, Laura, Budach, Wilfried, Bölke, Edwin, Matuschek, Christiane, Wollenberg, Andreas, Homey, Bernhard
7 Pages
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab - Scartozzi, Mario, Giampieri, Riccardo, Maccaroni, Elena, Mandolesi, Alessandra, Biagetti, Simona, Alfonsi, Simona, Giustini, Lucio, Loretelli, Cristian, Faloppi, Luca, Bittoni, Alessandro, Bianconi, Maristella, Del, Bearzi, Italo, Cascinu, Stefano
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab
Scartozzi, Mario, Giampieri, Riccardo, Maccaroni, Elena, Mandolesi, Alessandra, Biagetti, Simona, Alfonsi, Simona, Giustini, Lucio, Loretelli, Cristian, Faloppi, Luca, Bittoni, Alessandro, Bianconi, Maristella, Del, Bearzi, Italo, Cascinu, Stefano
10 Pages
expand_more